We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > EMERALD

News List

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021 prnasia
December 13, 2021
The Menarini Group ("Menarini") and Radius Health, Inc. ("Radius") (NASDAQ: RDUS) (collectively, the "Companies") provided details on the elacestrant data from the EMERALD trial following the positive results presented today...
Radius Health & Menarini Group Provide Elacestrant Update prnasia
September 27, 2020
Radius Health, Inc. and the Menarini Group announced an update on the elacestrant Phase 3 EMERALD trial.
Electromagnetic imaging using portable microwave devices europeanpharmaceuticalreview
April 19, 2019
The EMERALD project is supporting 13 PhD students for the development of a portable imaging device that can allow real-time imaging…